import { EducationalContent } from '../../types';

export const vsd: EducationalContent = {
  id: 'vsd',
  type: 'concept',
  name: 'Ventricular Septal Defect',
  nameEs: 'Comunicacion Interventricular',
  levels: {
    1: {
      level: 1,
      summary: 'A ventricular septal defect (VSD) is a hole in the wall between the two lower chambers of the heart, which is the most common congenital heart defect present at birth.',
      explanation: 'A ventricular septal defect, commonly called a VSD, is a hole in the wall (septum) that separates the two lower pumping chambers of the heart, called the ventricles. The left ventricle pumps oxygen-rich blood out to the body, while the right ventricle pumps oxygen-poor blood to the lungs. Normally, this wall keeps the two types of blood completely separate.\n\nWhen a VSD is present, some blood from the left ventricle (which is under higher pressure) is pushed through the hole into the right ventricle. This extra blood then gets pumped to the lungs, making the lungs and the left side of the heart work harder than normal. The larger the hole, the more blood crosses over and the harder the heart has to work.\n\nVSDs are the most common congenital heart defect, occurring in approximately 2-5 of every 1,000 live births. They can range from very small (pinhole-sized) to very large. Many small VSDs cause no symptoms and may close on their own during the first few years of life as the heart grows. In fact, up to 75% of small muscular VSDs close spontaneously.\n\nLarger VSDs can cause significant symptoms, especially in infants. These symptoms include difficulty feeding, poor weight gain, fast breathing, sweating during feedings, and frequent respiratory infections. If left untreated, large VSDs can eventually cause permanent damage to the blood vessels in the lungs.\n\nDoctors usually detect VSDs by hearing a heart murmur during a physical examination. The murmur is caused by blood flowing through the hole in the septum. An echocardiogram confirms the diagnosis by showing the size and location of the defect and how much extra blood is flowing through it.\n\nTreatment depends on the size of the VSD and the symptoms it causes. Small VSDs with no symptoms are simply monitored. Medium to large VSDs that cause symptoms or significant extra blood flow typically require closure, either through open-heart surgery or, in selected cases, through a catheter-based procedure.',
      keyTerms: [
        { term: 'Ventricular septal defect (VSD)', definition: 'A hole in the wall between the two lower pumping chambers of the heart, present from birth' },
        { term: 'Ventricles', definition: 'The two lower chambers of the heart that pump blood; the right ventricle pumps to the lungs and the left ventricle pumps to the body' },
        { term: 'Heart murmur', definition: 'An abnormal sound heard through a stethoscope caused by turbulent blood flow, often the first sign of a VSD' },
        { term: 'Septum', definition: 'The muscular wall that separates the left and right sides of the heart' },
        { term: 'Spontaneous closure', definition: 'The natural process where a small VSD closes on its own as the child grows, without needing surgery' }
      ],
      clinicalNotes: 'A VSD produces a holosystolic (pansystolic) murmur best heard at the left lower sternal border. Paradoxically, smaller restrictive VSDs often produce louder murmurs due to higher-velocity flow through the defect. In infants with large VSDs, symptoms of heart failure typically develop between 4-8 weeks of age as pulmonary vascular resistance falls from its elevated fetal levels, increasing the left-to-right shunt. All infants with suspected VSD should be referred for echocardiographic evaluation.'
    },
    2: {
      level: 2,
      summary: 'VSDs are classified anatomically as perimembranous, muscular, inlet, or outlet types, with hemodynamic significance determined by defect size relative to aortic annulus, pressure gradient, and Qp:Qs ratio, guiding management from observation to surgical or percutaneous closure.',
      explanation: 'Ventricular septal defects are classified by their anatomic location within the interventricular septum, which is composed of a small membranous portion and a larger muscular portion. Understanding VSD anatomy is essential for predicting natural history, associated anomalies, and treatment approach.\n\nPerimembranous VSDs (also called membranous or paramembranous) are the most common type, accounting for approximately 70-80% of VSDs. They occur in the membranous septum near the junction of the aortic, mitral, and tricuspid valves. Due to their proximity to the conduction system (the bundle of His passes along the posteroinferior rim), perimembranous VSDs carry a risk of heart block, both naturally and as a complication of surgical or device closure. These defects may partially close through adherence of the septal leaflet of the tricuspid valve, forming a tricuspid valve tissue aneurysm (sometimes called a ventricular septal aneurysm).\n\nMuscular VSDs account for approximately 15-20% of VSDs and occur entirely within the muscular septum. They may be single or multiple (Swiss cheese septum). Muscular VSDs have the highest rate of spontaneous closure (up to 75% for small defects) and can be located in the inlet, trabecular, or outlet portions of the muscular septum. Apical muscular VSDs can be technically challenging to close surgically due to their location.\n\nInlet VSDs (also called AV canal-type VSDs) account for approximately 5-8% of VSDs and occur in the posterior septum beneath the septal leaflets of the AV valves. They are commonly associated with Down syndrome and may be part of a complete atrioventricular septal defect (AVSD). These defects are close to the AV node and may be associated with conduction abnormalities.\n\nOutlet VSDs (also called supracristal, conal, subpulmonary, or doubly committed subarterial) account for approximately 5-7% of VSDs in Western populations but up to 30% in Asian populations. They are located in the outlet septum immediately beneath the pulmonary and aortic valves. Outlet VSDs do not close spontaneously and carry a specific risk of progressive aortic regurgitation due to prolapse of the right coronary cusp into the defect (loss of support from the conal septum).\n\nHemodynamic classification depends on defect size relative to the aortic annulus diameter. Restrictive VSDs are small (less than one-third of aortic annulus), create a significant pressure gradient between ventricles (left ventricular pressure greatly exceeds right ventricular pressure), and produce relatively small shunts. Moderately restrictive VSDs (one-third to two-thirds of aortic annulus) produce moderate shunting with some right ventricular pressure elevation. Non-restrictive VSDs are large (greater than two-thirds of aortic annulus), equalize pressures between the ventricles, and produce large shunts limited primarily by pulmonary vascular resistance.\n\nThe Qp:Qs ratio quantifies shunt magnitude. A ratio of 1.5:1 or greater indicates hemodynamically significant shunting. Large VSDs with Qp:Qs greater than 2:1 are at high risk for developing pulmonary vascular disease if not closed. In infants, signs of heart failure (tachypnea, diaphoresis with feeding, failure to thrive) develop as pulmonary vascular resistance falls in the first weeks of life, unmasking the full hemodynamic impact of the shunt.\n\nMedical management of heart failure in infants with large VSDs includes diuretics (furosemide), afterload reduction (ACE inhibitors such as captopril or enalapril), and nutritional optimization with calorie-dense formula. Surgical closure is recommended when medical therapy fails to control symptoms or when there is evidence of progressive pulmonary hypertension, typically before 6 months of age for large defects.',
      keyTerms: [
        { term: 'Perimembranous VSD', definition: 'The most common VSD type, occurring near the membranous septum adjacent to the aortic, mitral, and tricuspid valve junction, with proximity to the cardiac conduction system' },
        { term: 'Muscular VSD', definition: 'A VSD entirely within the muscular interventricular septum; has the highest rate of spontaneous closure and may occur as multiple defects' },
        { term: 'Outlet VSD', definition: 'A VSD in the outlet septum beneath the semilunar valves; does not close spontaneously and risks progressive aortic regurgitation from valve cusp prolapse' },
        { term: 'Restrictive VSD', definition: 'A small VSD that creates a significant pressure gradient between ventricles, limiting shunt volume; often produces a loud murmur despite small size' },
        { term: 'Non-restrictive VSD', definition: 'A large VSD that equalizes pressure between the ventricles, with shunt magnitude determined by the ratio of pulmonary to systemic vascular resistance' },
        { term: 'Ventricular septal aneurysm', definition: 'Tissue from the septal leaflet of the tricuspid valve that adheres to the edges of a perimembranous VSD, partially or completely closing the defect' }
      ],
      clinicalNotes: 'ECG findings vary with VSD size: small VSDs may have a normal ECG; moderate VSDs show left atrial enlargement and left ventricular hypertrophy (volume overload pattern); large non-restrictive VSDs show biventricular hypertrophy. On chest X-ray, cardiomegaly with increased pulmonary vascularity indicates significant shunting. An important clinical pearl: a VSD murmur that becomes softer over time in an infant may indicate either spontaneous closure (good) or rising pulmonary vascular resistance with decreasing left-to-right shunt (bad). Echocardiography is essential to differentiate these two scenarios.'
    },
    3: {
      level: 3,
      summary: 'VSD management integrates detailed hemodynamic assessment, natural history prediction based on anatomic subtype, surgical technique selection, timing of intervention to prevent irreversible pulmonary vascular disease, and management of associated lesions including aortic regurgitation and double-chambered right ventricle.',
      explanation: 'Comprehensive VSD management requires integration of anatomic classification, hemodynamic data, natural history prediction, and individualized surgical planning, with particular attention to associated anomalies and potential complications that influence timing and approach.\n\nNatural history varies significantly by VSD type. Small perimembranous VSDs have approximately 35-40% spontaneous closure rate by age 5, often through ventricular septal aneurysm formation. Small muscular VSDs have spontaneous closure rates of 60-75%. Outlet VSDs essentially never close spontaneously and require surgical closure, even if hemodynamically small, to prevent progressive aortic regurgitation. Inlet VSDs rarely close spontaneously.\n\nThe timing of surgical intervention is critical. For large non-restrictive VSDs causing heart failure, surgical closure should be performed before 6 months of age to prevent irreversible pulmonary vascular disease. The pulmonary vasculature develops irreversible medial hypertrophy and intimal proliferation (Heath-Edwards classification) in response to chronic high-flow, high-pressure exposure. Lung biopsy histology correlates with operative risk and reversibility: Grades I-III (medial hypertrophy, intimal proliferation) are generally reversible with VSD closure, while Grades IV-VI (plexiform lesions, dilation, necrotizing arteritis) represent irreversible disease. In current practice, catheterization with PVR assessment has largely replaced lung biopsy for operability assessment.\n\nSurgical closure techniques depend on VSD location and size. Perimembranous VSDs are approached through a right atriotomy with closure using a Dacron or Gore-Tex patch secured with interrupted pledgeted sutures. Sutures must be placed carefully along the posteroinferior rim, staying on the right ventricular side of the septum to avoid the bundle of His. The risk of surgically acquired complete heart block is approximately 1-2%. Muscular VSDs are more challenging surgically, particularly apical defects, and may require left ventriculotomy (which is avoided when possible due to long-term contractile impairment). The Hybrid approach for apical muscular VSDs combines a perventricular approach (device delivery through the right ventricular free wall via a mini-sternotomy under direct surgical and echocardiographic guidance) without cardiopulmonary bypass.\n\nPercutaneous device closure of VSDs is an expanding field. Muscular VSDs are most amenable to percutaneous closure using the Amplatzer Muscular VSD Occluder. Perimembranous VSD device closure has been more controversial due to proximity to the conduction system and aortic valve, with reported rates of complete heart block of 1-5%. Newer dedicated perimembranous VSD devices with softer, asymmetric disc designs aim to reduce these complications.\n\nAssociated anomalies requiring management include:\n\nAortic regurgitation with outlet VSDs: Progressive aortic cusp prolapse (usually the right coronary cusp) can develop even with small outlet VSDs. Early surgical closure is recommended to prevent progressive regurgitation, though established regurgitation may require concurrent aortic valve repair or replacement.\n\nDouble-chambered right ventricle (DCRV): An acquired condition where anomalous muscle bundles divide the right ventricle into a proximal high-pressure and distal low-pressure chamber. DCRV occurs in approximately 10% of VSD patients and produces progressive right ventricular outflow obstruction. Surgical resection of the obstructing bundles is performed concurrently with VSD closure.\n\nAortic valve prolapse: The right coronary cusp can prolapse through perimembranous or outlet VSDs due to the Venturi effect of high-velocity shunt flow. This may partially occlude the VSD (reducing the shunt) while causing progressive aortic regurgitation.\n\nEndocarditis: VSDs carry an ongoing risk of infective endocarditis, particularly at the site of the jet lesion on the right ventricular septum. Current guidelines no longer recommend routine antibiotic prophylaxis for unrepaired VSDs except in patients with prior endocarditis, prosthetic material within 6 months of placement, or residual defects adjacent to prosthetic material.',
      keyTerms: [
        { term: 'Heath-Edwards classification', definition: 'A histologic grading system (Grades I-VI) for pulmonary vascular disease severity, from reversible medial hypertrophy to irreversible plexiform lesions' },
        { term: 'Double-chambered right ventricle', definition: 'An acquired condition where anomalous muscle bundles obstruct the right ventricular outflow, occurring in approximately 10% of VSD patients' },
        { term: 'Hybrid perventricular closure', definition: 'A technique for muscular VSD closure combining surgical access through the RV free wall with catheter-delivered closure devices, avoiding cardiopulmonary bypass' },
        { term: 'Aortic cusp prolapse', definition: 'Prolapse of the right coronary cusp of the aortic valve into a VSD due to loss of structural support, causing progressive aortic regurgitation; most common with outlet VSDs' },
        { term: 'Bundle of His', definition: 'The cardiac conduction structure passing along the posteroinferior rim of perimembranous VSDs; injury during closure causes complete heart block' },
        { term: 'Pulmonary vascular resistance', definition: 'Resistance to blood flow through the lungs; elevated PVR from chronic high-flow shunting indicates pulmonary vascular disease and may contraindicate VSD closure' }
      ],
      clinicalNotes: 'Decision-making in VSD management requires integration of multiple factors. Small restrictive VSDs with Qp:Qs less than 1.5:1 and no RV pressure elevation can be observed. Indications for closure include Qp:Qs greater than 2:1, heart failure symptoms refractory to medical therapy, progressive aortic regurgitation with any outlet VSD, evidence of pulmonary vascular disease before it becomes irreversible (PA systolic pressure greater than 50% of systemic), and history of endocarditis. Perioperative monitoring for complete heart block is essential after surgical perimembranous VSD closure; temporary pacing wires should remain in place for 7-10 days postoperatively, and permanent pacemaker implantation may be needed if block persists beyond 7-10 days.'
    },
    4: {
      level: 4,
      summary: 'Complex VSD scenarios include management of residual and multiple VSDs, Gerbode-type defects, VSDs associated with other congenital lesions, catheter-based closure with emerging device technology, and management of adult patients with long-standing hemodynamic consequences.',
      explanation: 'Advanced VSD management addresses complex clinical scenarios that require specialized congenital heart disease expertise, advanced imaging, and multi-disciplinary decision-making.\n\nResidual VSDs after prior surgical closure occur in approximately 5-10% of patients and are usually small and hemodynamically insignificant. However, residual defects larger than 3 mm with persistent volume overload may require re-intervention. Percutaneous device closure is often preferred for residual VSDs to avoid the increased risk of redo sternotomy. Precise imaging with 3D TEE or cardiac MRI is essential for planning re-intervention.\n\nMultiple muscular VSDs (Swiss cheese septum) present a particular surgical challenge. Approaches include: (1) direct patch closure of each defect through a right ventriculotomy (limited by the difficulty of identifying all defects); (2) a single large patch on the left ventricular side of the septum (the Felt sandwich technique); (3) pulmonary artery banding as a staged palliative procedure in neonates, allowing some defects to close spontaneously before definitive repair; and (4) hybrid perventricular device closure of individual defects. Intraoperative TEE is essential to assess for residual defects before leaving the operating room.\n\nGerbode defect is an abnormal communication between the left ventricle and the right atrium, either directly through a deficiency of the membranous septum above the tricuspid valve attachment (direct type) or indirectly through a perimembranous VSD with concurrent deficiency of the septal tricuspid leaflet (indirect type). Gerbode defects can be congenital or acquired (post-endocarditis, post-surgical, post-myocardial infarction). They produce a high-velocity jet from the high-pressure LV to the low-pressure RA with a characteristic continuous or late systolic murmur. Transcatheter closure using Amplatzer Duct Occluder or Vascular Plug devices has been reported with increasing frequency.\n\nVSD in the context of other congenital heart lesions: VSD with coarctation of the aorta presents with biventricular failure as the coarctation increases left ventricular afterload while the VSD produces volume overload. Management involves coarctation repair first (which may reduce the left-to-right shunt by reducing the pressure gradient) with subsequent VSD closure if needed. VSD with interrupted aortic arch requires complete neonatal repair with arch reconstruction and VSD closure. VSD with tetralogy of Fallot is managed as part of the complete tetralogy repair. VSD with aortic regurgitation (from a prolapsing aortic cusp) may require aortic valve repair techniques including cusp resuspension, commissuroplasty, or free-margin plication.\n\nAdult patients with unrepaired VSDs may present with late complications including progressive pulmonary hypertension, atrial and ventricular arrhythmias, endocarditis, ventricular dysfunction from chronic volume overload, and Eisenmenger syndrome. Exercise capacity assessment with cardiopulmonary exercise testing provides objective functional data. Cardiac MRI offers precise quantification of biventricular volumes, function, Qp:Qs, and myocardial fibrosis burden.\n\nPost-myocardial infarction VSD is an acquired defect occurring in approximately 0.2% of acute MIs, typically 3-5 days after STEMI. It carries extremely high mortality (90% without intervention). The defect results from septal necrosis and rupture, usually involving the apical septum in anterior MI and the basal septum in inferior MI (often with associated RV involvement). Emergency surgical repair is the standard treatment, though operative mortality remains 20-40%. Temporary hemodynamic stabilization with an intra-aortic balloon pump or Impella device may bridge patients to surgery. Percutaneous device closure has been attempted in selected patients, though the friable necrotic tissue makes device anchoring unreliable in the acute phase.',
      keyTerms: [
        { term: 'Gerbode defect', definition: 'An abnormal communication between the left ventricle and the right atrium, either congenital or acquired, producing a high-velocity shunt with characteristic murmur' },
        { term: 'Swiss cheese septum', definition: 'Multiple muscular VSDs creating a sieve-like interventricular septum, presenting challenges for complete surgical closure' },
        { term: 'Pulmonary artery banding', definition: 'A palliative surgical procedure placing a constrictive band around the main pulmonary artery to limit pulmonary blood flow and pressure in patients with large VSDs who are not candidates for primary closure' },
        { term: 'Post-MI VSD', definition: 'An acquired ventricular septal defect from septal necrosis and rupture following acute myocardial infarction, carrying extremely high mortality without intervention' },
        { term: 'Felt sandwich technique', definition: 'A surgical approach for multiple muscular VSDs using a large felt or patch on the left ventricular side of the septum to cover all defects simultaneously' },
        { term: 'Perventricular device closure', definition: 'A hybrid technique delivering a closure device through the right ventricular free wall under surgical and echocardiographic guidance without cardiopulmonary bypass' }
      ],
      clinicalNotes: 'Post-MI VSD should be suspected when a new holosystolic murmur develops 3-5 days after STEMI, particularly with acute hemodynamic deterioration. Differentiate from acute mitral regurgitation (papillary muscle rupture) using echocardiography. Both conditions require urgent surgical intervention. For Gerbode defects, the high pressure differential between LV and RA produces velocities of 5-6 m/s on Doppler, which may be confused with tricuspid regurgitation. Careful interrogation of the jet origin (from the LV side of the septum rather than the tricuspid leaflets) is essential for correct diagnosis.'
    },
    5: {
      level: 5,
      summary: 'Expert-level VSD management encompasses molecular genetics of ventricular septation, tissue-engineered closure devices, computational hemodynamic modeling for complex decision-making, fetal diagnosis and intervention paradigms, and the emerging concept of the VSD as a lifelong cardiovascular risk modifier.',
      explanation: 'Expert-level understanding of ventricular septal defects integrates molecular developmental biology, bioengineering, advanced computational methods, and evolving paradigms in lifelong care for congenital heart disease.\n\nThe molecular genetics of ventricular septation involve complex signaling cascades coordinating the muscular septum (derived from trabeculated myocardium), the membranous septum (derived from endocardial cushion tissue), and the outlet septum (derived from neural crest cells). Key signaling pathways include TBX transcription factors (TBX5 for the muscular septum, TBX1 for the outlet septum), BMP/TGF-beta signaling for endocardial cushion development, and Hand transcription factors for trabecular morphogenesis. Disruption of GATA4, NKX2-5, or their interaction can produce isolated VSDs. The TBX1 haploinsufficiency in 22q11.2 deletion syndrome produces outlet-type VSDs along with conotruncal abnormalities. Epigenomic studies have identified differential DNA methylation patterns in VSD patients, suggesting that environmental exposures (folate deficiency, maternal diabetes, teratogen exposure) may modify genetic susceptibility through epigenetic mechanisms.\n\nTissue-engineered VSD patches represent the next generation of closure materials. Current research focuses on decellularized extracellular matrix scaffolds (derived from porcine small intestinal submucosa or pericardium) that provide a biological template for cellular repopulation, reducing foreign body reaction and growing with the patient. Cell-seeded biodegradable polymer scaffolds using autologous cells (bone marrow-derived mesenchymal stem cells or induced pluripotent stem cell-derived cardiomyocytes) are being investigated in animal models. The goal is to create living tissue patches that integrate with native myocardium, conduct electrical impulses (reducing heart block risk), and grow with the child.\n\nComputational hemodynamic modeling uses patient-specific cardiac anatomy from MRI or CT combined with computational fluid dynamics to simulate VSD hemodynamics under varying physiologic conditions. These models can predict the hemodynamic impact of VSD closure on biventricular function, coronary perfusion, and pulmonary hemodynamics. For complex cases with borderline PVR elevation, computational modeling may help predict whether closure will be tolerated or lead to right ventricular failure. Machine learning models trained on large surgical registries can predict outcomes (mortality, heart block, residual VSD, need for reoperation) from preprocedural variables, potentially improving patient counseling and surgical planning.\n\nFetal echocardiographic diagnosis of VSDs is increasingly common with high-resolution ultrasound technology. While isolated small muscular VSDs detected prenatally frequently close in utero or postnatally, the identification of perimembranous or outlet VSDs warrants serial fetal monitoring and delivery planning at centers with neonatal cardiac surgical capabilities. Fetal cardiac MRI using ultra-fast sequences is emerging as a complementary tool for complex fetal cardiac anatomy. Fetal cardiac intervention for VSD is not currently performed, but fetal pulmonary vasodilator therapy (maternal sildenafil administration) for associated pulmonary vascular disease is under investigation.\n\nThe concept of the VSD as a lifelong cardiovascular risk modifier is evolving. Even after successful closure, former VSD patients demonstrate increased incidence of hypertension, ventricular arrhythmias, and subtle biventricular dysfunction compared to age-matched controls. Myocardial fibrosis from chronic volume overload (detected by CMR late gadolinium enhancement and T1 mapping) may persist after hemodynamic correction and serves as a substrate for arrhythmias. Right bundle branch block after surgical closure is nearly universal and may contribute to long-term RV dyssynchrony. Left ventricular non-compaction may coexist with VSDs, sharing genetic susceptibility through sarcomere gene mutations.\n\nNext-generation percutaneous VSD devices under development include self-centering designs that reduce protrusion into the outflow tracts, conductive fabric-covered frames that allow electrical transmission across the device (potentially reducing heart block), and shape-memory alloy devices with biodegradable components. Three-dimensional printing of patient-specific septal anatomy enables pre-procedural device simulation, optimizing size selection and predicting potential complications such as tricuspid valve impingement or conduction system injury.\n\nThe integration of advanced imaging (4D flow MRI for shunt visualization, T1/T2 mapping for myocardial tissue characterization, strain analysis for subclinical dysfunction), computational modeling (hemodynamic simulation, outcome prediction), and genetic profiling (risk stratification for associated anomalies and arrhythmias) is creating a precision medicine framework for VSD management that tailors intervention timing, technique, and long-term surveillance to individual patient characteristics.',
      keyTerms: [
        { term: 'Tissue-engineered patches', definition: 'Next-generation VSD closure materials using decellularized biological scaffolds or biodegradable polymers seeded with autologous cells to create living tissue that integrates with native myocardium' },
        { term: 'TBX1 haploinsufficiency', definition: 'Reduced expression of the TBX1 transcription factor in 22q11.2 deletion syndrome, causing outlet-type VSDs and conotruncal abnormalities through disrupted neural crest cell migration' },
        { term: 'Epigenomic modification', definition: 'Environmentally influenced changes in DNA methylation and chromatin structure that alter cardiac gene expression during septation without changing the DNA sequence' },
        { term: 'Computational hemodynamic modeling', definition: 'Patient-specific mathematical simulation of cardiac blood flow using imaging-derived anatomy to predict hemodynamic consequences of VSD closure and guide clinical decisions' },
        { term: 'Fetal cardiac MRI', definition: 'An emerging imaging modality using ultrafast MRI sequences to complement fetal echocardiography for detailed prenatal assessment of complex congenital heart anatomy' },
        { term: 'Conductive closure devices', definition: 'Experimental VSD closure devices incorporating conductive materials to allow electrical signal transmission across the device, potentially reducing the risk of surgically induced heart block' }
      ],
      clinicalNotes: 'Genetic counseling should be offered to families with recurrent VSDs, particularly when outlet-type defects or associated anomalies suggest a genetic syndrome. CMR with late gadolinium enhancement provides the most sensitive assessment of post-closure myocardial fibrosis and should be considered in patients with persistent arrhythmias or ventricular dysfunction after VSD repair. Long-term follow-up of VSD patients should include periodic evaluation for exercise intolerance, arrhythmias, ventricular dysfunction, and endocarditis risk. The paradigm is shifting from viewing VSD closure as curative to recognizing it as one step in the lifelong management of a congenital cardiovascular condition.'
    }
  },
  media: [],
  citations: [
    { id: 'vsd-c1', source: 'Spicer DE, Hsu HH, Co-Vu J, et al. Ventricular Septal Defect. Orphanet J Rare Dis. 2014;9:144.', url: 'https://doi.org/10.1186/s13023-014-0144-2' },
    { id: 'vsd-c2', source: 'Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the Management of Adult Congenital Heart Disease. Eur Heart J. 2021;42(6):563-645.', url: 'https://doi.org/10.1093/eurheartj/ehaa554' },
    { id: 'vsd-c3', source: 'Yang J, Yang L, Wan Y, et al. Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J. 2010;31(18):2238-2245.', url: 'https://doi.org/10.1093/eurheartj/ehq240' }
  ],
  crossReferences: [
    { contentId: 'asd', relationship: 'related', description: 'Atrial septal defect is another common congenital septal defect with shared diagnostic and management principles' },
    { contentId: 'echo', relationship: 'related', description: 'Echocardiography is the primary diagnostic modality for VSD detection, classification, and hemodynamic assessment' },
    { contentId: 'cardiaccath', relationship: 'related', description: 'Cardiac catheterization provides hemodynamic assessment and enables percutaneous VSD closure' }
  ],
  tags: {
    defined: ['congenital-heart-disease', 'ventricular-septal-defect', 'shunt-lesion', 'pediatric-cardiology', 'structural-heart', 'surgical-repair'],
    generated: ['perimembranous', 'muscular-VSD', 'outlet-VSD', 'Eisenmenger', 'pulmonary-hypertension', 'device-closure']
  },
  createdAt: '2025-01-25',
  updatedAt: '2025-01-25',
  version: 2,
  status: 'published'
};
